Skip to Content

BL 322 (Relhist DMX dextromethorphan hydrobromide 15 mg / guaifenesin 380 mg / phenylephrine hydrochloride 10 mg)

Generic Name: dextromethorphan/guaifenesin/phenylephrine

Pill with imprint BL 322 is Yellow, Elliptical / Oval and has been identified as Relhist DMX dextromethorphan hydrobromide 15 mg / guaifenesin 380 mg / phenylephrine hydrochloride 10 mg. It is supplied by Burel Pharmaceuticals, Inc..

Relhist DMX is used in the treatment of cough and nasal congestion and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Relhist DMX dextromethorphan hydrobromide 15 mg / guaifenesin 380 mg / phenylephrine hydrochloride 10 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for BL 322

Relhist DMX

Generic Name
dextromethorphan/guaifenesin/phenylephrine
Imprint
BL 322
Strength
dextromethorphan hydrobromide 15 mg / guaifenesin 380 mg / phenylephrine hydrochloride 10 mg
Color
Yellow
Size
16.00 mm
Shape
Elliptical / Oval
Availability
Rx and/or OTC
Drug Class
Upper respiratory combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Burel Pharmaceuticals, Inc.
National Drug Code (NDC)
35573-0322
Inactive Ingredients
D&C Yellow No. 10, FD&C Yellow No. 6, magnesium stearate, microcrystalline cellulose, sodium starch glycolate type A corn

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.